Trials / Unknown
UnknownNCT05670015
Ocular Changes With Alpha-2 Receptor Agonist.
Ocular Changes After Selective Alpha-2 Receptor Agonist.
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 150 (estimated)
- Sponsor
- Benha University · Academic / Other
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
selective alpha-2 receptor agonists cause changes in intraocular pressure and pupillary size thus may affect patient quality of life.
Detailed description
In this research, we will analyze the effect of selective alpha-2 receptor agonists on the human eye and investigate ocular changes over 6 months after its topical use.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Low dosage selective alpha-2 receptor agonists topical eyedrop | Using selective alpha-2 receptor agonists eyedrop in both groups with 0.2% concentration. |
| DRUG | High dosage selective alpha-2 receptor agonists topical eyedrop | Using selective alpha-2 receptor agonists eyedrop in both groups with 0.02% concentration. |
Timeline
- Start date
- 2023-01-01
- Primary completion
- 2023-08-10
- Completion
- 2023-09-22
- First posted
- 2023-01-04
- Last updated
- 2023-01-04
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05670015. Inclusion in this directory is not an endorsement.